spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Presidio Pharmaceuticals 

 HSMN NewsFeed - 3 Jan 2017
Ascletis Raises US$100 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Sep 2015
Ascletis Secures US$35 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Nov 2012
BioCryst Pharmaceuticals and Presidio Pharmaceuticals Mutually Terminate Merger Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Oct 2012
BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2011
FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Mar 2011
XTL Biopharmaceuticals to Acquire MinoGuard Ltd.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Jan 2010
Eric Ruby Joins Presidio Pharmaceuticals, Inc. as Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2009
Tom Anderton Joins Presidio Pharmaceuticals, Inc. as Vice President of Intellectual Property and Legal Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2009
Dr. Nathaniel Brown Joins Presidio Pharmaceuticals, Inc. as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2008
Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL Biopharmaceuticals Ltd. Hepatitis C Virus (HCV) NS5A Program
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Mar 2008
XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Dec 2007
Medivir AB and Presidio Pharmaceuticals, Inc. Amend License Agreement.
Biopharmaceuticals HIV/AIDS Licensing
 HSMN NewsFeed - 18 Sep 2007
Presidio Pharmaceuticals Adds Industry Veteran Dr. Richard Colonno as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2007
Presidio Pharmaceuticals Closes $26 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jun 2007
Presidio Pharmaceuticals Announces Key Executive Management Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2007
Presidio Pharmaceuticals Receives Exclusive License to Novel Hepatitis C Virus (HCV) Technology from Stanford University
Biopharmaceuticals Licensing
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.